Editor's Note: This article, which discusses the salaries of executives at biotechnology companies, is the second in a two-part series. The first part, which appeared in the April 29, 1991, issue of The Scientist, dealt with the salaries of middle managers and scientific staff at biotech firms.

The average total cash compensation for most biotechnology executives fell this year, according to an annual survey by J. Robert Scott, a Boston-based executive search firm specializing in technology, and the Boston-based National High Technology Group of Coopers & Lybrand, an accounting and consulting firm.

The study found that in 1991, total average cash compensation was expected to decline from the 1990 figures among five of seven executive job categories--vice presidents of operations/manufacturing, research and development, sales and marketing, and regulatory affairs, plus chief financial officers--mostly because companies held salaries in check as the economy worsened and financing became more difficult to obtain....

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?